Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Osteopore Ltd. ( (AU:OSX) ).
Osteopore Limited has announced a collaboration with Tan Tock Seng Hospital to develop a novel implant for treating avascular necrosis (AVN) at the hip joint. This partnership, funded by a SGD 50,000 MedTech grant from NHG Health, aims to enhance outcomes for core decompression in AVN and could potentially reduce healthcare costs. The AVN treatment market is projected to grow significantly, reaching USD 10.2 billion by 2030, driven by increased awareness and earlier diagnosis.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company specializing in 3D-printed biomimetic and bioresorbable implants.
Average Trading Volume: 3,169,900
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.61M
For a thorough assessment of OSX stock, go to TipRanks’ Stock Analysis page.